This is an interesting clinical finding that can further the exploration of the mechanism behind elevated EGFR expression in patients with primary breast cancer and the mechanism of EGFR expression in lung cancer and breast cancer, paving the way for development of new drugs. This evidence concerns the gene EGFR and breast cancer.